Search research articles
Contact Us
Filters
Showing results (261-270 of 286) with videos related to
Page
of 29
Sort By:
Tissue & Cell
|
May 29, 2019
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model
Kentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Anticancer Research
|
November 29, 2025
Rapid Eradication of Extensive Spinal Metastases in a Prostate-Cancer Patient Taking Androgen-deprivation Therapy, Chemotherapy, and Oral Recombinant Methioninase on a Low-Methionine Diet
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient
Yohei Asano, Toshihiko Sato, Chihiro Hozumi, et al.
Cancer Diagnosis & Prognosis
|
September 3, 2025
Eradication of Extensive Lymph-Node, Bone and Pleural Metastases of a Breast-Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase
Yohei Asano, Toshihiko Sato, Qinghong Han, et al.
Anticancer Research
|
May 6, 2020
Recombinant Methioninase Combined With Tumor-targeting <i>Salmonella typhimurium</i> A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma
Kentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Anticancer Research
|
May 6, 2020
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
Jun Yamamoto, Takuya Murata, Norihiko Sugisawa, et al.
Anticancer Research
|
September 15, 2019
Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma
Takashi Higuchi, Hiromichi Oshiro, Kentaro Miyake, et al.
Cancer Chemotherapy and Pharmacology
|
February 14, 2019
Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model
Kentaro Miyake, Tasuku Kiyuna, Kei Kawaguchi, et al.
Cancer Letters
|
October 23, 2019
Patient-derived orthotopic xenograft models of sarcoma
Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Cancer Genomics & Proteomics
|
April 30, 2020
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Norio Yamamoto, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 286) with videos related to
Sort By:
Page
of 29
Tissue & Cell
|
May 29, 2019
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model
Kentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Anticancer Research
|
November 29, 2025
Rapid Eradication of Extensive Spinal Metastases in a Prostate-Cancer Patient Taking Androgen-deprivation Therapy, Chemotherapy, and Oral Recombinant Methioninase on a Low-Methionine Diet
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient
Yohei Asano, Toshihiko Sato, Chihiro Hozumi, et al.
Cancer Diagnosis & Prognosis
|
September 3, 2025
Eradication of Extensive Lymph-Node, Bone and Pleural Metastases of a Breast-Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase
Yohei Asano, Toshihiko Sato, Qinghong Han, et al.
Anticancer Research
|
May 6, 2020
Recombinant Methioninase Combined With Tumor-targeting <i>Salmonella typhimurium</i> A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma
Kentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Anticancer Research
|
May 6, 2020
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
Jun Yamamoto, Takuya Murata, Norihiko Sugisawa, et al.
Anticancer Research
|
September 15, 2019
Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma
Takashi Higuchi, Hiromichi Oshiro, Kentaro Miyake, et al.
Cancer Chemotherapy and Pharmacology
|
February 14, 2019
Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model
Kentaro Miyake, Tasuku Kiyuna, Kei Kawaguchi, et al.
Cancer Letters
|
October 23, 2019
Patient-derived orthotopic xenograft models of sarcoma
Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Cancer Genomics & Proteomics
|
April 30, 2020
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Norio Yamamoto, et al.
Page
of 29